Abstract 165: Study of lobeglitazone for evaluation of safety and efficacy with active comparator pioglitazone in Indian T2DM patients: A randomized phase III trial (sensitize India)
Indian Journal of Endocrinology and Metabolism（2022）
关键词
indian t2dm patients,active comparator pioglitazone,lobeglitazone,phase iii trial,efficacy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要